Literature DB >> 19787796

HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.

James C Barton1, Susie A Lafreniere, Catherine Leiendecker-Foster, Honggui Li, Ronald T Acton, Richard D Press, John H Eckfeldt.   

Abstract

We sought to identify mutations that could explain iron phenotype heterogeneity in adults with previous HFE genotyping to detect C282Y and H63D. HEIRS Study participants genotyped for C282Y and H63D were designated as high transferrin saturation (TS) and/or serum ferritin (SF) (high TS/SF), low TS/SF, or controls. We grouped 191 C282Y homozygotes as high TS/SF, low TS/SF, or controls, and 594 other participants by race/ethnicity as high TS/SF or controls. Using denaturing high-performance liquid chromatography (DHPLC), we screened 20 regions of HFE, SLC40A1, HAMP, HJV, TFR2, and FTL in each participant. DHPLC analyses were successful in 99.3% of 791 participants and detected 117 different mutations. In C282Y homozygotes, 4.0% of high TS/SF participants had SLC40A1 Q248H, HAMP -72C>T, or HAMP R59G heterozygosity (0% Controls; P = 0.1200). In whites, 4.1% with high TS/SF and 1.3% of controls had HFE S65C or E168Q (P = 0.3049). HJV c.-6C>G and FTL L55L frequencies were greater in whites with high TS/SF than controls (0.0811 vs. 0.0200, P = 0.0144; 0.5743 vs. 0.4400, P = 0.0204, respectively). One Hispanic with high TS/SF (1.3%) had HAMP G71D heterozygosity. In blacks, SLC40A1 Q248H frequencies did not differ significantly between high TS/SF and control participants. Among Asians, 2.8% with high TS/SF were HFE V295A heterozygotes. Mutations other than HFE C282Y and H63D reported to be pathogenic were infrequently detected in high TS/SF participants. Genetic regions in linkage disequilibrium with HJV c.-6C>G and FTL L55L could partly explain high TS/SF phenotypes in whites. Am. J. Hematol., 2009. Published 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787796     DOI: 10.1002/ajh.21524

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  13 in total

1.  Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.

Authors:  Ronald T Acton; James C Barton; Catherine Leiendecker-Foster; Christopher Zaun; Christine E McLaren; John H Eckfeldt
Journal:  Blood Cells Mol Dis       Date:  2010-02-23       Impact factor: 3.039

2.  The hereditary hyperferritinemia-cataract syndrome: a family study.

Authors:  Javier Álvarez-Coca-González; María-Isabel Moreno-Carralero; Jorge Martínez-Pérez; Manuel Méndez; Marta García-Ros; María-Josefa Morán-Jiménez
Journal:  Eur J Pediatr       Date:  2010-07-09       Impact factor: 3.183

3.  Examining the clinical use of hemochromatosis genetic testing.

Authors:  Matthew B Lanktree; Bruce B Lanktree; Guillaume Paré; John S Waye; Bekim Sadikovic; Mark A Crowther
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jan-Feb

4.  Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload.

Authors:  Christine E McLaren; Mary J Emond; V Nathan Subramaniam; Pradyumna D Phatak; James C Barton; Paul C Adams; Justin B Goh; Cameron J McDonald; Lawrie W Powell; Lyle C Gurrin; Katrina J Allen; Deborah A Nickerson; Tin Louie; Grant A Ramm; Gregory J Anderson; Gordon D McLaren
Journal:  Hepatology       Date:  2015-03-18       Impact factor: 17.425

5.  Iron overload and cirrhosis in referred HFE p.C282Y homozygotes with normal transferrin saturation and elevated serum ferritin.

Authors:  Paul C Adams; James C Barton
Journal:  Can Liver J       Date:  2020-06-04

6.  Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Gordon D McLaren; Victor R Gordeuk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

7.  Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.

Authors:  Christine E McLaren; James C Barton; John H Eckfeldt; Gordon D McLaren; Ronald T Acton; Paul C Adams; Leora F Henkin; Victor R Gordeuk; Chris D Vulpe; Emily L Harris; Barbara W Harrison; Jacob A Reiss; Beverly M Snively
Journal:  Am J Hematol       Date:  2010-02       Impact factor: 10.047

8.  HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.

Authors:  Paul C Adams; Christine E McLaren; Mark Speechley; Gordon D McLaren; James C Barton; John H Eckfeldt
Journal:  Can J Gastroenterol       Date:  2013-07       Impact factor: 3.522

Review 9.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

Review 10.  Pathophysiological consequences and benefits of HFE mutations: 20 years of research.

Authors:  Ina Hollerer; André Bachmann; Martina U Muckenthaler
Journal:  Haematologica       Date:  2017-03-09       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.